Innovative health technologies offer significant opportunities for improving patient outcomes. At the same time, they raise important questions for healthcare systems: how to set appropriate prices, how to assess value under uncertainty and how to ensure sustainable and equitable access.
To contribute to these discussions, ASCERTAIN has developed three position papers:
- Pricing methods for innovative health technologies
- Cost-effectiveness and budget impact models for innovative health technologies
- Reimbursement for innovative health technologies
All three papers This position paper summarise the key findings from scoping literature reviews, outlines recommendations based on the evidence and explains how ASCERTAIN addresses these through concrete actions.